February 8th 2024
Phase 3 study reveals exebacase combined with standard antibiotics in treating methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis did not meet its primary endpoints.
February 19th 2020
Meta-Analysis On the Utility of Nasal Swabs to Rule Out MRSA Pneumonia
April 12th 2018Many patients with pneumonia are empirically treated with anti-MRSA therapy, leaving antimicrobial stewardship programs faced with the challenge of identifying patients who truly warrant continuation of this therapy.
Read More